Follow
Aleta Pupovac
Aleta Pupovac
Cartherics
Verified email at hudson.org.au
Title
Cited by
Cited by
Year
P2X7 receptor activation induces cell death and CD23 shedding in human RPMI 8226 multiple myeloma cells
AW Farrell, S Gadeock, A Pupovac, B Wang, I Jalilian, M Ranson, ...
Biochimica et Biophysica Acta (BBA)-General Subjects 1800 (11), 1173-1182, 2010
532010
Engineered CAR-T cells targeting TAG-72 and CD47 in ovarian cancer
R Shu, VJ Evtimov, MV Hammett, NYN Nguyen, J Zhuang, PJ Hudson, ...
Molecular Therapy-Oncolytics 20, 325-341, 2021
472021
Activation of the P2X7 receptor induces the rapid shedding of CD23 from human and murine B cells
A Pupovac, NJ Geraghty, D Watson, R Sluyter
Immunology and cell biology 93 (1), 77-85, 2015
422015
Murine epidermal Langerhans cells and keratinocytes express functional P2X7 receptors
JNSN Tran, A Pupovac, RM Taylor, JS Wiley, SN Byrne, R Sluyter
Experimental Dermatology 19 (8), e151-e157, 2010
342010
Human P2X7 receptor activation induces the rapid shedding of CXCL16
A Pupovac, CM Foster, R Sluyter
Biochemical and Biophysical Research Communications 432 (4), 626-631, 2013
332013
P2X7 receptor activation mediates organic cation uptake into human myeloid leukaemic KG-1 cells
S Gadeock, A Pupovac, V Sluyter, M Spildrejorde, R Sluyter
Purinergic signalling 8, 669-676, 2012
292012
Roles of extracellular nucleotides and P2 receptors in ectodomain shedding
A Pupovac, R Sluyter
Cellular and molecular life sciences 73, 4159-4173, 2016
252016
CAY10593 inhibits the human P2X7 receptor independently of phospholipase D1 stimulation
A Pupovac, L Stokes, R Sluyter
Purinergic signalling 9, 609-619, 2013
232013
Enhancing a natural killer: Modification of NK cells for cancer immunotherapy
R Islam, A Pupovac, V Evtimov, N Boyd, R Shu, R Boyd, A Trounson
Cells 10 (5), 1058, 2021
222021
An antigen to remember: regulation of B cell memory in health and disease
A Pupovac, KL Good-Jacobson
Current opinion in immunology 45, 89-96, 2017
222017
Group A Streptococcus modulates host inflammation by manipulating polymorphonuclear leukocyte cell death responses
JA Tsatsaronis, D Ly, A Pupovac, O Goldmann, M Rohde, JM Taylor, ...
Journal of Innate Immunity 7 (6), 612-622, 2015
132015
CAR-T cell development for Cutaneous T cell Lymphoma: current limitations and potential treatment strategies
V To, VJ Evtimov, G Jenkin, A Pupovac, AO Trounson, RL Boyd
Frontiers in Immunology 13, 968395, 2022
102022
‘Off-the-Shelf’ Immunotherapy: Manufacture of CD8+ T Cells Derived from Hematopoietic Stem Cells
N Boyd, K Cartledge, H Cao, V Evtimov, A Pupovac, A Trounson, R Boyd
Cells 10 (10), 2631, 2021
92021
Engineering T cell receptor fusion proteins using nonviral CRISPR/Cas9 genome editing for cancer immunotherapy
R Shu, M Hammett, V Evtimov, A Pupovac, NY Nguyen, R Islam, J Zhuang, ...
Bioengineering & Translational Medicine 8 (6), e10571, 2023
2023
Transcriptional and epigenetic regulation of germinal centre and plasma cell differentiation
K Good-Jacobson, A Di Pietro, A Pupovac
EUROPEAN JOURNAL OF IMMUNOLOGY 46, 1072-1072, 2016
2016
Memory B cell subset formation in acute and chronic viral disease
A Pupovac, K Good-Jacobson
EUROPEAN JOURNAL OF IMMUNOLOGY 46, 1128-1128, 2016
2016
Front & Back Matter
TE O'Sullivan, MM Berrien-Elliott, JA Wagner, TA Fehniger, JY Wu, ...
Journal of Innate Immunity 7 (6), 2015
2015
P2X7 receptor-induced CD23 shedding from B cells
A Pupovac
2014
Human P2X7 receptor activation induces ADAM10-mediated shedding of CD23 and CXCL16 (P4137)
A Pupovac, B Wang, C Foster, R Sluyter
The Journal of Immunology 190 (1_Supplement), 112.2-112.2, 2013
2013
Human P2X7 receptor activation induces ADAM10-mediated shedding of CD23 and CXCL16 (P4137)
A Pupovac, B Wang, C Foster, R Sluyter
The Journal of Immunology 190 (1_Supplement), 112.2-112.2, 2013
2013
The system can't perform the operation now. Try again later.
Articles 1–20